ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Outcomes with Steroids Alone for Biopsy-Proven Pancreas Transplant Rejection.

S. Salahuddin,1 B. Astor,1 S. Parajuli,1 A. Djamali,1 J. Odorico,2 D. Mandelbrot.1

1Department of Nephrology, University of Wisconsin, Madison, WI
2Department of Surgery, University of Wisconsin, Madison, WI.

Meeting: 2016 American Transplant Congress

Abstract number: A68

Keywords: Graft failure, Pancreas transplantation, Rejection

Session Information

Date: Saturday, June 11, 2016

Session Name: Poster Session A: Clinical Pancreas Transplantation and All Islet Cell Transplantation Topics

Session Time: 5:30pm-7:30pm

 Presentation Time: 5:30pm-7:30pm

Location: Halls C&D

Related Abstracts
  • Which Place of Pancreas Graft Biopsy in the Management of Pancreas Transplant Recipients?
  • Evaluation of Leflunomide for the Treatment of BK Viremia and Biopsy Proven BK Nephropathy: A Single Center Experience

There is little published data on the response of pancreas rejection to steroids alone. We reviewed 42 pancreas transplant recipients between 01/1997 and 12/2013 at our institution who had biopsy-proven first pancreas rejection and were treated with steroid pulse alone. Patients with borderline rejection on biopsy and those who received anti-thymocyte globulin (ATG) within four days of biopsy were excluded. Response to treatment was defined as normalization of lipase on day 14 which persisted at least 60 days. Patients not meeting this criterion or receiving ATG four or more days after biopsy were considered non-responders.

There were no significant differences in baseline characteristics between responders and non-responders (Table). 21 of 34 (62%) of patients with grade 1 rejection responded to treatment with steroids alone, while only 1 of 7 (14%) patients with grade 2 or 3 rejection responded. A trend toward more graft failure within one year from biopsy among non-responders was present, but did not reach statistical significance. One-year graft failure was 9% in patients with grade 1, 33.3% in grade 2 and 50% in grade 3 rejection (p-trend=0.01).

We conclude that many patients with grade 1 pancreas transplant rejection can be treated with steroids alone – most patients will respond with normalization of pancreas enzymes and graft failure is rare. In contrast, grade 2 and 3 rejection rarely responds to steroids alone and is associated with high graft failure rates. Higher grade rejection should probably be treated initially with ATG plus steroids, although further research is required to investigate outcomes with that approach.

CITATION INFORMATION: Salahuddin S, Astor B, Parajuli S, Djamali A, Odorico J, Mandelbrot D. Outcomes with Steroids Alone for Biopsy-Proven Pancreas Transplant Rejection. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Salahuddin S, Astor B, Parajuli S, Djamali A, Odorico J, Mandelbrot D. Outcomes with Steroids Alone for Biopsy-Proven Pancreas Transplant Rejection. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/outcomes-with-steroids-alone-for-biopsy-proven-pancreas-transplant-rejection/. Accessed March 6, 2021.

« Back to 2016 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Role of Mitochondria, Metabolism and Inflammation: Pathways Influencing Short Term Outcomes Post-Renal Transplantation
    • Factors Influencing Creatinine Rise Following Donor Nephrectomy

    Visit Our Partner Sites

    American Transplant Congress (ATC)

    Visit the official site for the American Transplant Congress »

    American Journal of Transplantation

    The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

    American Society of Transplantation (AST)

    An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

    American Society of Transplant Surgeons (ASTS)

    The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

    Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

    Privacy Policy

    loading Cancel
    Post was not sent - check your email addresses!
    Email check failed, please try again
    Sorry, your blog cannot share posts by email.
    This site uses cookies: Find out more.